Matt McKenna

Born and raised in Massachusetts, Matt has spent the last 18yrs working in the Cambridge area in both large pharma and small biotech settings. While mostly focused on transient protein expression, Matt also has extensive experience in developing stable cell lines expressing monoclonal antibodies. Most recently at Pfizer, Matt helped develop an automated platform approach to transiently express hundreds of proteins per week in the Expi293 system.

Pin It on Pinterest